Devil’s Claw Root (Harpagophytum procumbens): The Joint and Pain Herb
Devil’s Claw — Harpagophytum procumbens — is a creeping plant native to the Kalahari desert of Southern Africa, named for the extraordinary hooked thorns on its fruits that cling tenaciously to animal fur. Its large secondary tubers — the medicinal part — have been used by the San and Khoikhoi peoples of Southern Africa for centuries for digestive conditions, fever, and rheumatic pain. Introduced to European herbal medicine in the early 20th century, Devil’s Claw has since accumulated one of the strongest clinical evidence bases of any herbal anti-inflammatory — comparable in several clinical trials to pharmaceutical NSAIDs for osteoarthritis and back pain, with a significantly more favourable gastric safety profile.
At Herba Naturalle, Devil’s Claw is listed in the comprehensive herb index as a primary anti-inflammatory and analgesic herb — working at the level of the smooth muscle and connective tissue that underlies chronic inflammatory conditions.
Active Compounds
- Iridoid glycosides — harpagoside (the primary active compound), harpagide, and procumbide; inhibit NF-κB and COX-2 inflammatory pathways; reduce prostaglandin and cytokine production
- Acteoside (verbascoside) — a phenylpropanoid glycoside with significant anti-inflammatory and antioxidant activity
- Sugars (stachyose) — contributing to the digestive tonic properties
Clinical Evidence
The evidence base for Devil’s Claw is extensive and clinically significant:
Osteoarthritis: Multiple RCTs and systematic reviews confirm statistically significant reductions in pain, improved mobility, and reduced analgesic consumption in osteoarthritis of the hip and knee with standardised Devil’s Claw extract. Several head-to-head trials show efficacy comparable to low-dose NSAIDs for mild-to-moderate OA pain.
Lower back pain: A Cochrane-reviewed meta-analysis found Devil’s Claw extract (standardised to 50mg harpagoside daily) significantly superior to placebo for non-specific low back pain — with one trial showing comparable efficacy to rofecoxib (a COX-2 inhibitor).
Rheumatoid arthritis: Supporting evidence for reductions in pain and morning stiffness in RA.
Clinical Applications
- Osteoarthritis — hip, knee, and hand
- Non-specific lower back pain
- Rheumatoid arthritis (as adjunct support)
- Tendinitis and sports injuries
- General musculoskeletal pain with inflammatory component
The Smooth Muscle and Immune Reset Bundle addresses the deep smooth muscle lining inflammation underlying many chronic joint and musculoskeletal conditions.
How to Use
- Standardised extract (50mg harpagoside daily): The form used in clinical trials; 400–800mg of 2.5% harpagoside extract twice daily
- Tincture (1:3): 4–6ml three times daily
- Allow 4–8 weeks for full anti-inflammatory benefit to develop
Safety
- Well tolerated with an excellent safety record in multiple long-term trials
- Gastric ulcer: Although much better tolerated than NSAIDs, high doses may cause digestive irritation — take with food
- Anticoagulants: Mild interaction possible — professional guidance alongside warfarin
- Diabetes medication: May modestly lower blood glucose — monitor
- Pregnancy: Contraindicated — harpagoside has oxytocic potential
- Gallstones: The bitter action may trigger biliary discomfort — professional guidance
Contact Herba Naturalle for joint and anti-inflammatory herbal support. Browse the full herb index, herbal philosophy, and all products.
This article is for informational purposes only. Please consult a qualified medical herbalist before use.